Browse the evidence

Nose-to-brain (N2B) pathways can address limitations of the subcutaneous route for GLP-1 RAs.

Practitioners should explore N2B pathways as a viable alternative for delivering GLP-1 RAs.

There is no significant change in resting state functional connectivity (RSFC) after the semaglutide intervention compared to the placebo group in the investigated regions of interest (ROIs).

Practitioners can consider that semaglutide does not significantly alter RSFC related to suicidal ideation and behavior in this population.

The change in RSFC between visits did not differ significantly between the groups.

This indicates that semaglutide does not lead to significant changes in RSFC over the study period compared to placebo.

OXT/GLP-1 co-administration increases c-Fos expression in the PVN and supraoptic nucleus.

Increased neuronal activation in specific brain regions may underlie the effects on food intake and body weight.

Amylin and salmon calcitonin target distinct neurons in various brain regions.

Insights into neural targeting can inform obesity treatment strategies.

Tirzepatide effectively attenuated the rewarding properties of alcohol, measured through locomotor stimulation, conditioned place preference, and accumbal dopamine release.

Tirzepatide may be a potential treatment for reducing alcohol consumption and its rewarding effects.

In women with type 2 diabetes, cardiovascular autonomic neuropathy (CAN) is significantly associated with an increased risk of all-cause mortality (CAN1: HR 1.64, CAN2: HR 1.58, CAN3: HR 1.78) and cardiovascular disease mortality (CAN1: HR 2.25, CAN2: HR 2.22, CAN3: HR 3.31).

Healthcare providers should prioritize monitoring CAN in women with type 2 diabetes to mitigate mortality risk.

Sugar-sweetened beverage companies have successfully marketed their products by associating them with global cultural and sporting events.

Awareness of marketing tactics can help consumers make informed choices about beverage consumption.

The BB-Health study will evaluate age-sensitive cognitive assessments and cerebral hemodynamics as outcomes.

Practitioners should monitor cognitive health and cerebral hemodynamics in interventions.

GLP-1 receptor agonists (GLP-1RAs) may have neuroprotective and neurotrophic effects in ALS models.

GLP-1RAs may be considered for further investigation in ALS treatment.

Preoperative screening and interdisciplinary coordination are important for patients using GLP-1 RAs undergoing ophthalmic surgery.

Healthcare teams should ensure thorough preoperative assessments for these patients.

Increasing levels of neurofilament light chain (NfL) are associated with worsening cognitive function and incident mild cognitive impairment or probable dementia.

Monitoring NfL levels may help in assessing cognitive decline in patients with T2D and obesity.

Increasing levels of glial fibrillary acidic protein (GFAP) are associated with worsening cognitive function and incident mild cognitive impairment or probable dementia.

Tracking GFAP levels may provide insights into cognitive health in patients with T2D and obesity.

Innovative therapeutics focused on hunger control are being considered for patients with rare genetic obesities.

Clinicians may consider new pharmacological options for managing hunger in patients with rare genetic obesities.

No significant difference in fatigue index for knee extensors and flexors was observed between acai supplementation and placebo.

Acai supplementation does not appear to affect fatigue levels in knee extensors and flexors post-exercise.

The association between T2D subgroups and MCI/PD was not modified by the Action for Health in Diabetes (Look AHEAD) lifestyle intervention.

Lifestyle interventions may not be sufficient to alter cognitive decline risks in certain T2D subgroups.

Individuals in the younger onset T2D subgroup have the lowest risk for peripheral neuropathy.

Younger individuals with T2D may require different monitoring for PN risk.

The impact of intensive lifestyle intervention (ILI) on peripheral neuropathy risk does not differ by T2D subgroups.

ILI may not be effective in reducing PN risk across different T2D subgroups.

Greater hypothalamic inflammation and gliosis may predict adiposity gain and worsening insulin sensitivity.

Monitoring hypothalamic inflammation could be important for predicting weight gain and metabolic decline.

A variety of clinical tools exist to assess nutritional status, sarcopenia, and physical frailty in liver transplant recipients.

Practitioners should utilize available assessment tools to evaluate frailty and nutritional status in liver transplant patients.

Bariatric surgery has been the primary approach to treating obese individuals.

Practitioners should consider bariatric surgery as a primary treatment option for obesity.